Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BECTON DICKINSON & CO Director's Dealing 2023

Mar 4, 2023

30003_dirs_2023-03-03_5d6ed079-bd62-429c-acb4-0fbb421fcd34.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2023-03-01

Reporting Person: Garrison Michael David (EVP & President Medical)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-01 Common Stock F 193 $0.0 Disposed 6457 Direct

Footnotes

F1: Represents shares withheld for payment of withholding taxes in connection with vesting of restricted stock units previously reported on Table I.